07:00 , Jun 20, 2016 |  BC Week In Review  |  Company News

EnBiotix, Mayo Clinic deal

EnBiotix and Mayo Clinic partnered to develop EnBiotix’s EPP-001 . The product, an engineered bacteriophage that uses customized phages coding for biofilm-degrading enzyme payloads, is in preclinical testing to treat prosthetic joint infections. The partners...